Sabrina Dunbar
Investor Relations
Replay available
GeneDx Holdings Corp. (NASDAQ: WGS) Q4 2025 earnings conference call, held 2026-02-23. Replay captured from the company's public earnings webcast.

Investor Relations
President & Chief Executive Officer
Chief Financial Officer
Analyst, Guggenheim
Analyst, Craig-Hallam
Analyst, Canaccord Genuity
Analyst, Piper Sandler
Analyst, TD Cowen
Analyst, Jefferies
Analyst, Freedom Capital Markets
Analyst, Wells Fargo
Analyst, BTIG
Good day, and thank you for standing by. Welcome to the GeneDx Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Sabrina Dunbar, Investor Relations. Please go ahead. Thank you, Operator, and thank you to everyone for joining us today. On the call, we have Catherine Stuland, President and Chief Executive Officer, and Kevin Feely, Chief Financial Officer. Earlier today, GDX released financial results for the fourth quarter, ended December 31, 2025. Before we begin, please take note of our cautionary statements. We may make forward-looking statements on today's call, including about our business plans, guidance, and outlook. Forward-looking statements inherently involve risks and uncertainties and only reflect our view as of today, February 23rd, and we're under no obligation to update. When discussing our results, we refer to non-GAAP measures, which exclude certain items from reported results. Please refer to our fourth quarter 2025 earnings release and slides available. at ir.gbx.com for definitions and reconciliations of non-GAAP measures and additional information regarding our results, including a discussion of factors that could cause actual results to materially differ from forward-looking statements. And with that, I'll turn the call over to Catherine. Thank you, Sabrina, and good morning, every...